骨质疏松症治疗中的特定胶原蛋白肽:通过专家视角和科学见解揭示治疗潜力

Dr. Amitava N Mukherjee, Dr. Sanjay Londhe, Dr. PV Shyam Prasad, Dr. Nagraj Shetty, Dr. Santosh Shetty, Dr. Nishikant Kumar, Dr. AK Jinsiwale, Dr. KM Ponnanna, Dr. R Balamurugan, Dr. Niranjan Rathod, Dr. Sunil Katoch, Dr. Vivek Mittal, Dr. Hemant Thacker, Dr. Manish R Garg, Dr. Anish Desai
{"title":"骨质疏松症治疗中的特定胶原蛋白肽:通过专家视角和科学见解揭示治疗潜力","authors":"Dr. Amitava N Mukherjee, Dr. Sanjay Londhe, Dr. PV Shyam Prasad, Dr. Nagraj Shetty, Dr. Santosh Shetty, Dr. Nishikant Kumar, Dr. AK Jinsiwale, Dr. KM Ponnanna, Dr. R Balamurugan, Dr. Niranjan Rathod, Dr. Sunil Katoch, Dr. Vivek Mittal, Dr. Hemant Thacker, Dr. Manish R Garg, Dr. Anish Desai","doi":"10.22271/ortho.2024.v10.i1c.3513","DOIUrl":null,"url":null,"abstract":"Background: Osteoporosis, characterized by reduced bone mineral density, increased fracture risk and impaired quality of life, remains a significant global health concern. Collagen, serving as the foundational structure for bone mineralization, emerges as a crucial component in the armamentarium against osteoporosis. Objective: This expert opinion captures insights from a panel of experts, highlighting the role of specific collagen peptides in the management of osteopenia and osteoporosis. Methods: To achieve this consensus, a group of 13 orthopedics experts from across India came together in Mumbai on 15 th October 2023 to review the existing clinical data and discuss the role of specific collagen peptides in the management of osteopenia and osteoporosis. Results: Collagen, as the fundamental structural component for bone mineralization, emerges as a critical element in osteoporosis management. Specific Collagen Peptide, being a small chain of amino acids, is easily absorbed from the GI tract and, via the circulatory system, reaches the bone marrow, where it activates the formation of osteoblast from bone marrow stem cells plus also inhibits the activity of osteoclast through an increase in the OPG/RANKL ratio. Specific Collagen Peptides (SCP) demonstrated enhancements in Bone Mineral Density (BMD) by 4.2% in the spine and 7.7% in the femoral neck, coupled with alterations in bone turnover markers in 12 months. A clinically relevant increase in BMD was observed in the 4-year follow-up study; no fractures were reported by any patients, and no drug interaction and tolerability issues were noted in the study. Conclusion: The consensus among experts underscores the necessity of integrating once-a-day oral 5 gm specific collagen peptide supplementation (Nutra with a drug-like action) into standard osteoporosis management. SCP, with its dual action on both osteoblast and osteoclast (Along with Calcium and vitamin D), can be used stand-alone or can be used for its synergistic action when used along with anti-resorptive (Bisphosphonate/denosumab) as well as anabolic (teriparatide) treatment.","PeriodicalId":14302,"journal":{"name":"International Journal of Orthopaedics Sciences","volume":"13 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Specific collagen peptides in osteoporosis management: Unraveling therapeutic potential through expert perspectives and scientific insights\",\"authors\":\"Dr. Amitava N Mukherjee, Dr. Sanjay Londhe, Dr. PV Shyam Prasad, Dr. Nagraj Shetty, Dr. Santosh Shetty, Dr. Nishikant Kumar, Dr. AK Jinsiwale, Dr. KM Ponnanna, Dr. R Balamurugan, Dr. Niranjan Rathod, Dr. Sunil Katoch, Dr. Vivek Mittal, Dr. Hemant Thacker, Dr. Manish R Garg, Dr. Anish Desai\",\"doi\":\"10.22271/ortho.2024.v10.i1c.3513\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Osteoporosis, characterized by reduced bone mineral density, increased fracture risk and impaired quality of life, remains a significant global health concern. Collagen, serving as the foundational structure for bone mineralization, emerges as a crucial component in the armamentarium against osteoporosis. Objective: This expert opinion captures insights from a panel of experts, highlighting the role of specific collagen peptides in the management of osteopenia and osteoporosis. Methods: To achieve this consensus, a group of 13 orthopedics experts from across India came together in Mumbai on 15 th October 2023 to review the existing clinical data and discuss the role of specific collagen peptides in the management of osteopenia and osteoporosis. Results: Collagen, as the fundamental structural component for bone mineralization, emerges as a critical element in osteoporosis management. Specific Collagen Peptide, being a small chain of amino acids, is easily absorbed from the GI tract and, via the circulatory system, reaches the bone marrow, where it activates the formation of osteoblast from bone marrow stem cells plus also inhibits the activity of osteoclast through an increase in the OPG/RANKL ratio. Specific Collagen Peptides (SCP) demonstrated enhancements in Bone Mineral Density (BMD) by 4.2% in the spine and 7.7% in the femoral neck, coupled with alterations in bone turnover markers in 12 months. A clinically relevant increase in BMD was observed in the 4-year follow-up study; no fractures were reported by any patients, and no drug interaction and tolerability issues were noted in the study. Conclusion: The consensus among experts underscores the necessity of integrating once-a-day oral 5 gm specific collagen peptide supplementation (Nutra with a drug-like action) into standard osteoporosis management. SCP, with its dual action on both osteoblast and osteoclast (Along with Calcium and vitamin D), can be used stand-alone or can be used for its synergistic action when used along with anti-resorptive (Bisphosphonate/denosumab) as well as anabolic (teriparatide) treatment.\",\"PeriodicalId\":14302,\"journal\":{\"name\":\"International Journal of Orthopaedics Sciences\",\"volume\":\"13 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Orthopaedics Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22271/ortho.2024.v10.i1c.3513\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Orthopaedics Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22271/ortho.2024.v10.i1c.3513","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:骨质疏松症以骨矿物质密度降低、骨折风险增加和生活质量下降为特征,仍然是一个重大的全球健康问题。胶原蛋白是骨矿化的基础结构,是防治骨质疏松症的重要组成部分。目的:本专家意见收集了专家小组的见解,强调了特定胶原蛋白肽在骨质疏松和骨质疏松症治疗中的作用。方法:为了达成这一共识,来自印度各地的 13 位骨科专家于 2023 年 10 月 15 日齐聚孟买,回顾现有的临床数据,讨论特定胶原蛋白肽在骨质增生和骨质疏松症治疗中的作用。会议结果胶原蛋白是骨矿化的基本结构成分,是治疗骨质疏松症的关键因素。特异性胶原蛋白肽是一条小的氨基酸链,很容易被消化道吸收,并通过循环系统到达骨髓,激活骨髓干细胞形成成骨细胞,并通过增加 OPG/RANKL 比率抑制破骨细胞的活性。12 个月后,特异性胶原蛋白肽(SCP)显示脊柱的骨密度(BMD)提高了 4.2%,股骨颈提高了 7.7%,同时骨转换标志物也发生了变化。在为期 4 年的随访研究中,观察到了临床相关的骨密度增加;没有任何患者报告骨折,研究中也没有发现药物相互作用和耐受性问题。结论专家们达成的共识强调,有必要将每日一次口服 5 克特异性胶原蛋白肽补充剂(具有类药物作用的 Nutra)纳入标准骨质疏松症治疗中。SCP 对成骨细胞和破骨细胞(以及钙和维生素 D)具有双重作用,既可单独使用,也可与抗骨吸收(双磷酸盐/地诺单抗)和合成代谢(特立帕肽)治疗一起使用,发挥协同作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Specific collagen peptides in osteoporosis management: Unraveling therapeutic potential through expert perspectives and scientific insights
Background: Osteoporosis, characterized by reduced bone mineral density, increased fracture risk and impaired quality of life, remains a significant global health concern. Collagen, serving as the foundational structure for bone mineralization, emerges as a crucial component in the armamentarium against osteoporosis. Objective: This expert opinion captures insights from a panel of experts, highlighting the role of specific collagen peptides in the management of osteopenia and osteoporosis. Methods: To achieve this consensus, a group of 13 orthopedics experts from across India came together in Mumbai on 15 th October 2023 to review the existing clinical data and discuss the role of specific collagen peptides in the management of osteopenia and osteoporosis. Results: Collagen, as the fundamental structural component for bone mineralization, emerges as a critical element in osteoporosis management. Specific Collagen Peptide, being a small chain of amino acids, is easily absorbed from the GI tract and, via the circulatory system, reaches the bone marrow, where it activates the formation of osteoblast from bone marrow stem cells plus also inhibits the activity of osteoclast through an increase in the OPG/RANKL ratio. Specific Collagen Peptides (SCP) demonstrated enhancements in Bone Mineral Density (BMD) by 4.2% in the spine and 7.7% in the femoral neck, coupled with alterations in bone turnover markers in 12 months. A clinically relevant increase in BMD was observed in the 4-year follow-up study; no fractures were reported by any patients, and no drug interaction and tolerability issues were noted in the study. Conclusion: The consensus among experts underscores the necessity of integrating once-a-day oral 5 gm specific collagen peptide supplementation (Nutra with a drug-like action) into standard osteoporosis management. SCP, with its dual action on both osteoblast and osteoclast (Along with Calcium and vitamin D), can be used stand-alone or can be used for its synergistic action when used along with anti-resorptive (Bisphosphonate/denosumab) as well as anabolic (teriparatide) treatment.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信